Yuan Z, Li D, Feng P, Xue G, Ji C, Li G et al (2017) A novel GLP-1/GIP dual agonist is more effective than liraglutide in reducing inflammation and enhancing GDNF release in the MPTP mouse model of Parkinsons disease
The rise of prescription drugs such as GLP-1 agonists (Ozempic, Wegovy, Rybelsus, Trulicity, Victoza, and Saxenda
The medication works by regulating your insulin levels and slowing down digestion
The potentially modifiable risk factor in idiopathic intracranial hypertension: body weight
Why it matters: Farxiga increases glucose excretion, which creates an osmotic pull that increases urine output
Glutamine, glycine, N-acetylcysteine, selenium, whey protein isolates with bonded cysteine, GSH and pro-GSH supplementation improves GSH deficiency, oxidative stress, mitochondrial dysfunction, inflammation, insulin resistance, endothelial dysfunction, genotoxicity, muscle strength, cognition and surfactant regeneration (301307)